SIBIONICS Showcases AI-Powered GS3 Glucose Monitoring, Advances Integrated Diabetes Care at Melbourne Congress ...
Thermo Fisher Scientific is reinforcing its commitment to China as the country emerges as an increasingly important source of ...
The pharmaceutical services major increases its interim shareholder payout from RMB 1.03 billion in 2025, while continuing to ...
Data4Life and Monash Health have partnered to optimize clinical trial design and execution, complemented by educational ...
- Topline data from the AURORA Phase III clinical program are expected in the third quarter of 2028, with a U.S. Food and ...
METHOD IN BRIEF Cost-of-goods figures in this article are reconstructions, not disclosures. No company supplied a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results